PDS Biotechnology Corporation - PDSB Company Short-Term Debt

pdsbiotech.com (PDSB) - corporate logo

PDS Biotechnology depends on funding and the outcome of Versamune tests. Short-term borrowings under one year on the GURU.Markets base chart contain data where 0.00 is the current value of the indicator. Growth potential is based on T-cell therapy for cancer patients, while business protection relies on patent developments that have not yet generated commercial profit.

PDSB: PDS Biotechnology Corp Short-Term Debt 07/04/2022 - 10/28/2026

PDSB (PDS Biotech): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart PDS Biotechnology Corp|PDSB - Average Forecast Price
- market capitalization data:
Market Value PDS Biotechnology Corporation|PDSB - Total Company Value
- book capitalization data:
Net Assets per Single Share PDS Biotechnology|PDSB - Total Stockholders' Equity|Market Capitalization to Book Value Ratio pdsbiotech.com|PDSB - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Equity Ratio PDS Biotechnology|PDSB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio PDS Biotechnology Corp|PDSB - Aggregate Debt Obligations|Debts to Book Capitalization PDS Biotechnology Corporation|PDSB - Long-Term Debt Volume|Company Short-Term Debt PDS Biotechnology
Analysis of all company metrics:pdsbiotech.com PDSB
Finished products of PDS Biotechnology

With negative cash flow, PDS Biotechnology is critically dependent on external financing, making the monitoring of short-term debt with maturities of up to one year a key tool for assessing liquidity. This indicator captures obligations with a repayment horizon of up to twelve months, allowing for a comparison between the growth rate of the credit load and the absence of commercial revenue to determine the sustainability of the innovative business.

Competitor analysis for PDS Biotechnology

IBRX (ImmunityBio) - Company Short-Term Debt|IMCR: Short-Term Debt|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt ZYME (Zymeworks Inc.)|Short-Term Debt tangotx.com|IOVA: Company Short-Term Debts|Short-Term Indebtedness Immatics NV IMTX|XNCR: Company Current Liabilities|CMPX - Short-Term Debt|Company Current Liabilities Replimune Group, Inc. (REPL)|LYEL - Company Short-Term Loans and Borrowings|Innate Pharma - Company Short-Term Debts|PYXS (Pyxis Oncology) - Short-Term Debt Volume|Company Short-Term Debt CGEN|Company Current Liabilities IOBT|Company Short-Term Debt STRO (Sutro Biopharma, Inc.)|Company Current Liabilities minktherapeutics.com INKT|Company Current Liabilities HOWL (Werewolf Therapeutics, Inc.)|Immix Biopharma Inc. - Company Short-Term Debts|ALX Oncology (ALXO) - Company Short-Term Debt|CUE: Company Short-Term Indebtedness|Company Short-Term Debt SONN|Short-Term Debt MAIABiotech.com|Liminatus Pharma LLC - Company Current Liabilities|Short-Term Indebtedness Lava Tx (LVTX)|Company Current Liabilities NextCure Corp|Amount of Current Liabilities leaptx.com (LPTX)|Company Short-Term Debts Intensity Therapeutics, Inc.|Company Short-Term Loans and Borrowings Sensei Biotherapeutics Inc SNSE|TOVX (Theriva Biologics) - Company Short-Term Debts|GRTS: Short-Term Debt|Company Short-Term Debt Kineta Bio KA|NexImmune Corporation (NEXI) - Company Short-Term Loans and Borrowings|TSBX (Turnstone Biologics Corp) - Company Short-Term Debts|Company Short-Term Debts VCNX|HARP - Company Short-Term Debt